← Human Trials & Peer-Reviewed Studies
Exogenous growth hormone: effects on the catabolic response to surgically produced acute stress and on postoperative immune function.
Plain-language guide to PMID 8362531 (1993): double-blind randomized controlled trial of Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in 180 patients, post-surgical inflammation and surgery recovery.
Key Facts
- PMID
- 8362531
- Journal
- World journal of surgery
- Year
- 1993
- Study type
- Randomized Controlled Trial
- Authors
- Vara-Thorbeck R et al. (5 authors)
- DOI
- 10.1007/BF01655116
What This Study Did, in Plain Language
What Was Tested
This randomized controlled trial looks at Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in the context of post-surgical inflammation and surgery recovery.
The first purpose of the present prospective randomized study was to determine if the protein catabolic response after operation could be restrained by administration of hypocaloric parenteral nutrition (HPN) plus human growth hormone (hGH).
Why It Was Studied
The researchers performed a placebo-controlled randomized double-blind trial in 180 patients after elective cholecystectomy with or without choledochoduodenostomy (placebo = control group, n = 93; hGH-treated group, n = 87).
The potassium balance tended to follow the same positive balance as the nitrogen balance.
Who Took Part
According to the abstract, 180 patients were involved.
PubMed indexes the participants as middle-aged adults.
How the Study Was Run
The researchers set it up as a randomized, double-blind and placebo-controlled study.
Because people in this Exogenous HGH, sermorelin & older GHRPs (why they're passed over) study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.
Blinding on both sides kept the patients and researchers unaware of who received Exogenous HGH, sermorelin & older GHRPs (why they're passed over).
The comparison arm used a placebo, so changes seen with Exogenous HGH, sermorelin & older GHRPs (why they're passed over) could be set against what happens without it.
What Was Measured
Topics PubMed links to this paper include Blood Proteins, Cholecystectomy, Choledochostomy, Growth Hormone, Immunocompetence, Liver and Parenteral Nutrition, Total.
What This Means in Plain Language
The paper is a randomized, double-blind and placebo-controlled study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in 180 patients in people with post-surgical inflammation and surgery recovery.
The publication is from 1993 (World journal of surgery), a journal based in United States.
More context: the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) compound page, Post-surgical inflammation and surgery recovery research.
Our Notes on the Compound
Exogenous HGH, sermorelin & older GHRPs (why they're passed over): Constant levels suppress the body's own GHRH, raise somatostatin and dull pituitary response.
Related Pages
- Post-surgical inflammation and surgery recovery research
- Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in the library
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.